Earnings Outlook For Arrowhead Pharma
Portfolio Pulse from Benzinga Insights
Arrowhead Pharma (NASDAQ:ARWR) is expected to release its quarterly earnings report on Wednesday, 2023-11-29, with an estimated EPS of $-0.60. Investors are looking for a beat on this estimate and positive guidance for future growth. Historically, Arrowhead's stock price has been sensitive to earnings performance and guidance, with a 10.78% drop after missing EPS last quarter. Over the past year, ARWR shares have declined by 11.96%.
November 28, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Arrowhead Pharma is anticipated to report quarterly earnings with an estimated EPS of $-0.60. Investors are focused on earnings performance and future guidance, which historically have impacted the stock price significantly.
The short-term impact on ARWR's stock price will likely hinge on whether the company beats the EPS estimate and provides positive future guidance. Given the historical sensitivity of the stock to earnings reports, a beat or miss could lead to significant price movements. However, the score is neutral (0) because the direction of the impact depends on the actual earnings results and guidance, which are unknown at this point.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100